Classical Reporting System

Classical reporting system

Contexte	Official surveillance system relies on official laws. The Lebanese Law related to communicable diseases issued on the 31st December 1957 requests from physicians and healthcare facilities to report to the MOPH selected communicable diseases. On the other hand, the MOPH issues continuously decisions, circulars, and memos that specifies technical aspects of the national surveillance system (case definitions, forms…).
Objectives	- Measure disease burden and describe the characteristics. This includes: a) Measure incidence, prevalence, and mortality rates; b) Describe event/disease by time, place and person; c) Monitor trends; d) Identify high risk populations or areas; e) Identify risk factors; f) Evaluate specific diseases control programs. - Detect alerts and outbreaks. The detection of an outbreak gives an opportunity to investigate, find etiologies and implement corrective measures, thus aiming to reduce cases and prevent later outbreaks. Early warning and response system refers to the outbreak detection at early stages; when timely corrective measures can prevent additional new cases and stop the natural evolution of the outbreak.
Target diseases and syndromes	40 diseases and syndromes are targetted by the classical surveillance system. The diseases are displayed in 2 groups: immediate notification and weekly notification: - The immediate notifiable diseases and syndromes are: Acute Flaccid Paralysis, Anthrax, Cholera, Diphtheria, Food Poisoning, Hemorrhagic Fever, Influenza novel viruses, Invasive Coranaviruses, Measles, Meningitis, Meningococcal infection, Mumps, Pertussis, Plague, Rabies, Rubella and Congenital Rubella Syndrome, Smallpox, Tetanus including Tetanus Neonatorum, and Unusual Event - The weekly notifiable diseases and syndromes are: Bilharziasis, Brucellosis, Creutzfeldt-Jakob Disease (Transmissible Spongiform Encephalopathy), Gonococcal Infection,Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis E, Human Immunodeficiency Virus, Human T-cell Lymphotropic Virus 1, Hydatid Disease, Intestinal Infections, Legionellosis, Leishmaniasis, Leprosy, Malaria, Syphilis, Tuberculosis, Typhoid Fever and Typhus.
Data Sources	All Physicians and Healthcare facilities
Guidelines	- Communicable diseases surveillance guideline: Ar, En - Communicable diseases surveillance standard operating procedures - part 1 (immediately notifiable diseases): En - Communicable diseases surveillance standard operating procedures - part 2 (weekly notifiable diseases): En
Case definitions	Refer to webpages "Notifiable Diseases"
Form	Reporting form
Results	Refer to webpage "Surveillance data"

...

194

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A11DB	3V	G	Vitamin B12 - 200mcg, Vitamin B6 - 200mg, Vitamin B1 - 100mg		Tablet	229,797 L.L
A11DB	3V	G	Vitamin B12 - 1mg/3ml, Vitamin B6 - 100mg/3ml, Vitamin B1 - 100mg/3ml		Injectable solution	198,889 L.L
B05BB02	5% DEXTROSE 0.45% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.45g/100ml		Injectable solution	179,272 L.L
B05BB02	5% DEXTROSE 0.45% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.45g/100ml		Injectable solution	224,090 L.L
B05BB02	5% DEXTROSE 0.45% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.45g/100ml		Injectable solution	153,990 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	180,421 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	226,388 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	153,990 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	159,736 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	179,272 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	208,002 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	224,090 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
L01BC02	5-FLUOROURACIL EBEWE	G	Fluorouracil - 1000mg/20ml	1000mg/20ml	Injectable concentrated solution	653,107 L.L
L01BC02	5-FROTU	G	Fluorouracil - 1000mg/20ml	1000mg/20ml	Injectable solution	577,852 L.L
L01BC02	5-FROTU	G	Fluorouracil - 1000mg/20ml	1000mg/20ml	Injectable solution	L.L
B05CX01	7.5% DEXTROSE INJECTION USP	G	Dextrose monohydrate - 7.5%	7.5g/100ml	Injectable solution	202,256 L.L
B05XA03	9% SODIUM CHLORIDE	G	Sodium chloride - 9g/100ml	0.9%	Injectable solution	255,118 L.L
N01BB02	? 1% LIDOCAINE HCL USP	G	Lidocaine HCl - 1%	1%	Injectable solution	76,791 L.L
N01BB02	? 2% LIDOCAINE HCL USP	G	Lidocaine HCl - 2%	2%	Injectable solution	255,970 L.L
H02AB02	? DEXAMETHASONE SODIUM PHOSPHATE USP	G	Dexamethasone (sodium phosphate) - 8mg/2ml	8mg/2ml	Injectable solution	44,795 L.L
C03CA01	? FUROSEMIDE INJECTION	G	Furosemide - 20mg/ml	20mg/ml	Injectable solution	25,597 L.L
A03BB01	? HYOSCINE BUTYLBROMIDE	G	Hyoscine butylbromide - 20mg/ml	20mg/ml	Injectable solution	70,392 L.L
M01AE01	? IBUPROFEN	G	Ibuprofen - 400mg/100ml	400mg/100ml	Injectable solution	383,955 L.L
A03FA01	? METOCLOPRAMIDE INJECTION USP	G	Metoclopramide HCl - 10mg/2ml	10mg/2ml	Injectable solution	84,470 L.L
P01AB01	? METRONIDAZOL	G	Metronidazole - 500mg/100ml	500mg/100ml	Injectable solution	162,541 L.L

...

194